Drugs / YY1201
last change Oct 2016 re-read 3 minutes ago

YY1201

Developed for
osteoarthritis, knee
Investigated by
Yooyoung Pharmaceutical Co., Ltd.

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02554552 Sep 2015 → Oct 2016 osteoarthritis, knee Yooyoung Pharmaceutical Co., Ltd. Withdrawn No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as YY1201 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02554552 ↗
Route Other “Intra-articular YY1201” NCT02554552 ↗